OTC Markets OTCPK - Delayed Quote USD

PolyNovo Limited (CALZF)

0.8490
0.0000
(0.00%)
At close: May 22 at 4:00:00 PM EDT
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
103,192
103,192
65,241.4690
41,439.8390
29,157.9240
Cost of Revenue
5,479
5,479
4,433.6960
2,202.6860
1,555.3930
Gross Profit
97,713
97,713
60,807.7730
39,237.1530
27,602.5310
Operating Expense
96,550
96,550
66,992.7950
39,493.8080
30,750.0210
Operating Income
1,163
1,163
-6,185.0220
-256.6550
-3,147.4900
Net Non Operating Interest Income Expense
814
814
155.4620
-314.6950
-320.3000
Other Income Expense
-266
-266
1,096.4620
-579.5740
-1,082.6140
Pretax Income
1,711
1,711
-4,933.0980
-1,150.9240
-4,550.4040
Tax Provision
-3,550
-3,550
-8.5590
41.6080
54.6280
Net Income Common Stockholders
5,261
5,261
-4,924.5390
-1,192.5320
-4,605.0320
Basic EPS
0.01
0.01
-0.01
-0.00
-0.01
Diluted EPS
0.01
0.01
-0.01
-0.00
-0.01
Basic Average Shares
690,232.7510
690,232.7510
684,454.1640
660,874.4060
661,189.9620
Diluted Average Shares
701,466.6670
701,466.6670
684,454.1640
660,874.4060
661,189.9620
Net Income from Continuing & Discontinued Operation
5,261
5,261
-4,924.5390
-1,192.5320
-4,605.0320
Normalized Income
5,261
5,261
-4,924.5390
-229.4496
-4,605.0320
Interest Income
1,535
1,535
869.6250
0.6710
1.1030
Interest Expense
141
141
186.1190
220.1500
222.6320
Net Interest Income
814
814
155.4620
-314.6950
-320.3000
EBIT
1,852
1,852
-4,746.9790
-930.7740
-4,327.7720
EBITDA
4,047
4,047
-2,709.5170
658.2420
-3,407.0880
Reconciled Cost of Revenue
5,479
5,479
4,433.6960
2,202.6860
1,555.3930
Reconciled Depreciation
2,195
2,195
2,037.4620
1,589.0160
920.6840
Net Income from Continuing Operation Net Minority Interest
5,261
5,261
-4,924.5390
-1,192.5320
-4,605.0320
Total Unusual Items Excluding Goodwill
--
--
--
-1,375.8320
--
Total Unusual Items
--
--
--
-1,375.8320
--
Normalized EBITDA
4,047
4,047
-2,709.5170
2,034.0740
-3,407.0880
Tax Rate for Calcs
0.0003
0.0003
0
0.0003
0.0003
Tax Effect of Unusual Items
0
0
0
-412.7496
0
6/30/2021 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SSKN STRATA Skin Sciences, Inc.
2.5900
+4.86%
 
RCEL AVITA Medical, Inc.
6.28
-1.87%
 
LAB Standard BioTools Inc.
0.9216
-3.45%
 
SYK Stryker Corporation
376.62
-0.44%
 
QSI Quantum-Si incorporated
1.9400
+11.49%
 
MDT Medtronic plc
80.68
-0.28%